Claire Clelland

• University of California, San Francisco

Sources: reporter.nih.gov

• National Institute on Aging

  R01, CRISPR for tauopathy, R01AG092420, 2026–2030, Jan 30, 2026

• Alzheimer's Association

  NIAP, Developing CRISPR genome therapy for Alzheimer's disease, NIAP24-1272942, 2024, Jan 1, 2024

Sources: reporter.nih.gov, openalex.org